Central Securities Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CET research report →
Price Chart
About the company
Central Securities Corporation functions as a publicly traded entity specializing in investment management. The firm primarily allocates capital within the United States' public stock markets. Additionally, it broadens its investment portfolio to include a diverse range of assets such as various bonds (including convertible and preferred types), warrants, options, and real estate.
- CEO
- John C. Hill
- IPO
- 1980
- Employees
- 6
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on CET
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.52B
- P/E
- 6.91
- PEG
- 10.23
- P/S
- 13.20
- P/B
- 0.83
- EV/EBITDA
- 7.01
- Div Yield
- 6.43%
- Gross Margin
- 94.83%
- Op Margin
- 188.50%
- Net Margin
- 188.50%
- ROE
- 11.99%
- ROIC
- 11.81%
Latest fiscal year · YoY change
- Revenue
- $86.95M-70.6%
- Gross Profit
- $81.25M-72.6%
- Op Income
- $265.21M
- Net Income
- $265.21M-7.9%
- EPS
- $9.15-9.8%
- OCF Growth
- +26.2%
- FCF Growth
- +26.3%
- 52W High
- $57.49
- 52W Low
- $48.00
- 50D MA
- $55.69
- 200D MA
- $53.41
- Beta
- 0.74
- RSI (14)
- 31
- Avg Volume
- 27.88K
No earnings-call transcripts are available for CET yet.
- Free Float
- 58.9%
- Shares Outstanding
- 29.55M
- Float Shares
- 17.40M
of shares held by institutions
100 13F filers
Buy/sell ratio 1.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Atlas Wealth LLC | 630.46K | ▲ 14.90K |
| Bulldog Investors, Llp | 457.76K | ▲ 10.50K |
| Blue Bell Private Wealth Management, LLC | 431.28K | ▲ 46.22K |
| Rockefeller Capital Management L.P. | 390.29K | 0 |
| Raymond James Financial Inc | 325.23K | ▲ 24.82K |
| Morgan Stanley | 195.14K | ▼ 3.59K |
| 1607 Capital Partners, LLC | 188.04K | ▼ 400 |
| Chilton Investment Co Inc. | 117.16K | 0 |
| Brasada Capital Management, LP | 111.84K | ▼ 5.16K |
| Todd Wealth Management, LLC | 107.57K | ▲ 525 |
| Third Avenue Management LLC | 101.81K | 0 |
| Pathstone Holdings, LLC | 91.99K | ▼ 2.44K |
Held by 1 ETFs
Biggest fund positions in CET by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 26, 26 | ENDEAVOR FOUNDATION, INC. | other | 18,000 |
| Oct 6, 26 | Hill John C | buy | 500 |
| Jun 26, 26 | Hill John C | buy | 228 |
| Jun 26, 26 | Hill John C | buy | 5 |
| Jun 26, 26 | Blackford Leo Price | buy | 204 |
| Jun 18, 26 | ENDEAVOR FOUNDATION, INC. | other | 38,200 |
| May 19, 26 | ENDEAVOR FOUNDATION, INC. | other | 19,000 |
| Apr 22, 26 | ENDEAVOR FOUNDATION, INC. | other | 18,750 |
| Mar 26, 26 | ENDEAVOR FOUNDATION, INC. | other | 20,160 |
| Feb 26, 26 | ENDEAVOR FOUNDATION, INC. | other | 19,200 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CET coverage
Recent articles, reports, and earnings notes.
No research on CET yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CET report →Invitation to presentation of BioArctic's third quarter report for July - September 2026 on November 25 at 9:30 a.m. CET
prnewswire.com · Nov 18
Weekly Closed-End Fund Roundup (November 8, 2026)
seekingalpha.com · Nov 17
newcleo to Host Q3 2026 Business Update Call on November 18, 2026
globenewswire.com · Nov 11
Zealand Pharma conference call on Nov 12 at 2pm CET (8am ET) to present third quarter 2026 financial results
globenewswire.com · Nov 5
Central Securities Corporation Declares Year-End Distribution
businesswire.com · Nov 4
Central Securities Corporation Releases Report to Stockholders
businesswire.com · Oct 27
Publication of the Q3 2026 financial results on Tuesday, November 3, 2026, after market close
globenewswire.com · Oct 27
Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) Congress
gurufocus.com · Oct 18
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.